PCSK9 pipeline

被引：0
|
作者：
Mullard, Asher
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2016年 / 15卷 / 12期
关键词：
D O I：
10.1038/nrd.2016.258
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：811 / 811
页数：1
相关论文
共 50 条
  • [31] PCSK9 inhibitors are go
    Asher Mullard
    Nature Reviews Drug Discovery, 2015, 14 : 593 - 593
  • [32] Pushing the envelope with PCSK9
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (07) : 506 - 506
  • [33] PCSK9: Is it Fluoride for Cardiology?
    King, Spencer B., III
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (11) : 1331 - 1332
  • [34] The promises of PCSK9 inhibition
    Petrides, Francine
    Shearston, Kate
    Chatelais, Mathias
    Guilbaud, Florian
    Meilhac, Olivier
    Lambert, Gilles
    CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (04) : 307 - 312
  • [35] PCSK9 Mediates Atherogenesis
    Sun, Hua
    Krauss, Ronald M.
    Teng, Ba-bie
    CIRCULATION, 2016, 134
  • [36] PCSK9 antagonists and inflammation
    Ruscica, Massimiliano
    Ferri, Nicola
    Corsini, Alberto
    Sirtori, Cesare R.
    ATHEROSCLEROSIS, 2018, 268 : 235 - 236
  • [37] PCSK9 function and physiology
    Peterson, Andrew S.
    Fong, Loren G.
    Young, Stephen G.
    JOURNAL OF LIPID RESEARCH, 2008, 49 (06) : 1152 - 1156
  • [38] Regulation of PCSK9 by nutraceuticals
    Momtazi, Amir Abbas
    Banach, Maciej
    Pirro, Matteo
    Katsiki, Niki
    Sahebkar, Amirhossein
    PHARMACOLOGICAL RESEARCH, 2017, 120 : 157 - 169
  • [39] PCSK9 in metabolism and diseases
    Ajoolabady, Amir
    Pratico, Domenico
    Mazidi, Mohsen
    Davies, Ian G.
    Lip, Gregory Y. H.
    Seidah, Nabil
    Libby, Peter
    Kroemer, Guido
    Ren, Jun
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2025, 163
  • [40] PCSK9 and diabetes: is there a link?
    Momtazi, Amir Abbas
    Banach, Maciej
    Pirro, Matteo
    Stein, Evan A.
    Sahebkar, Amirhossein
    DRUG DISCOVERY TODAY, 2017, 22 (06) : 883 - 895
12345